Table 6 Objective tumour response
From: Phase I trial of oral S-1 combined with gemcitabine in metastatic pancreatic cancer
Response | ||||||
|---|---|---|---|---|---|---|
Dose level | No. of patients | CR | PR | SD | PD | Response rate (%) |
Level 1 | 3 | 0 | 1 | 2 | 0 | 33 |
Level 2a | 6 | 1 | 3 | 1 | 1 | 67 |
Level 2b | 12 | 0 | 5 | 3 | 4 | 42 |
Total | 21 | 1 | 9 | 6 | 5 | 48 |
